MA41337A - Dérivés de l'hydroxyalkyl pipérazine utilisés comme modulateurs du récepteur cxcr3 - Google Patents

Dérivés de l'hydroxyalkyl pipérazine utilisés comme modulateurs du récepteur cxcr3

Info

Publication number
MA41337A
MA41337A MA041337A MA41337A MA41337A MA 41337 A MA41337 A MA 41337A MA 041337 A MA041337 A MA 041337A MA 41337 A MA41337 A MA 41337A MA 41337 A MA41337 A MA 41337A
Authority
MA
Morocco
Prior art keywords
receptor modulators
derivatives used
piperazine derivatives
cxcr3 receptor
hydroxyalkyl piperazine
Prior art date
Application number
MA041337A
Other languages
English (en)
Inventor
Eva Caroff
Emmanuel Meyer
Original Assignee
Idorsia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idorsia Pharmaceuticals Ltd filed Critical Idorsia Pharmaceuticals Ltd
Publication of MA41337A publication Critical patent/MA41337A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

L'invention concerne des composés de formule (i) dans laquelle n, x, r<sup>1</sup> et r<sup>2</sup> sont tels que définis dans la description; des sels pharmaceutiquement acceptables de ceux-ci, et l'utilisation de tels composés en tant que médicaments, en particulier en tant que modulateurs du récepteur cxcr3
MA041337A 2015-01-15 2016-01-14 Dérivés de l'hydroxyalkyl pipérazine utilisés comme modulateurs du récepteur cxcr3 MA41337A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP2015050696 2015-01-15

Publications (1)

Publication Number Publication Date
MA41337A true MA41337A (fr) 2017-11-22

Family

ID=55129886

Family Applications (1)

Application Number Title Priority Date Filing Date
MA041337A MA41337A (fr) 2015-01-15 2016-01-14 Dérivés de l'hydroxyalkyl pipérazine utilisés comme modulateurs du récepteur cxcr3

Country Status (38)

Country Link
US (1) US10053457B2 (fr)
EP (1) EP3245203B1 (fr)
JP (1) JP6337218B2 (fr)
KR (1) KR101967083B1 (fr)
CN (1) CN107250133B (fr)
AR (1) AR103414A1 (fr)
AU (1) AU2016207988B2 (fr)
BR (1) BR112017015093A2 (fr)
CA (1) CA2972952C (fr)
CL (1) CL2017001831A1 (fr)
CO (1) CO2017008156A2 (fr)
CY (1) CY1121361T1 (fr)
DK (1) DK3245203T3 (fr)
EA (1) EA032927B1 (fr)
ES (1) ES2709985T3 (fr)
HK (1) HK1246789B (fr)
HR (1) HRP20190024T1 (fr)
HU (1) HUE042559T2 (fr)
IL (1) IL253411B (fr)
LT (1) LT3245203T (fr)
MA (1) MA41337A (fr)
MX (1) MX2017009288A (fr)
MY (1) MY187614A (fr)
NZ (1) NZ734542A (fr)
PE (1) PE20171100A1 (fr)
PH (1) PH12017501280B1 (fr)
PL (1) PL3245203T3 (fr)
PT (1) PT3245203T (fr)
RS (1) RS58349B1 (fr)
SA (1) SA517381905B1 (fr)
SG (1) SG11201705617XA (fr)
SI (1) SI3245203T1 (fr)
TN (1) TN2017000278A1 (fr)
TR (1) TR201900680T4 (fr)
TW (1) TWI693221B (fr)
UA (1) UA119805C2 (fr)
WO (1) WO2016113344A1 (fr)
ZA (1) ZA201705486B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015011099A1 (fr) 2013-07-22 2015-01-29 Actelion Pharmaceuticals Ltd Dérivés de 1-(pipérazin-1-yl)-2-([1,2,4]triazol-1-yl)-éthanone
AR099789A1 (es) 2014-03-24 2016-08-17 Actelion Pharmaceuticals Ltd Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina
TR201900680T4 (tr) * 2015-01-15 2019-02-21 Idorsia Pharmaceuticals Ltd CXCR3 Reseptör modülatörleri olarak hidroksialkil- piperazin türevleri.
AR103399A1 (es) 2015-01-15 2017-05-10 Actelion Pharmaceuticals Ltd Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3
WO2018011265A1 (fr) * 2016-07-13 2018-01-18 Idorsia Pharmaceuticals Ltd Dérivés de l'hydroxyalkyl pipérazine utilisés comme modulateurs du récepteur cxcr3
WO2020060964A1 (fr) * 2018-09-18 2020-03-26 Alxerion Biotech Corp. Dérivés de 1, 2, 4-oxadiazole et leurs utilisations
AU2022215025A1 (en) 2021-01-28 2023-09-14 Idorsia Pharmaceuticals Ltd Crystalline form of a piperazinyl-thiazole derivative
WO2024052445A1 (fr) 2022-09-09 2024-03-14 Idorsia Pharmaceuticals Ltd Combinaison pharmaceutique comprenant un anticorps anti-cd3 et un antagoniste de cxcr3

Family Cites Families (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7186715B2 (en) 2001-01-08 2007-03-06 Eli Lilly And Company Piperazine- and piperidine-derivatives as melanocortin receptor agonists
WO2002059107A1 (fr) 2001-01-23 2002-08-01 Eli Lilly And Company Piperidines/piperazines substituees utilisees comme agonistes du recepteur de melanocortine
HUP0303484A2 (hu) 2001-03-02 2004-01-28 Bristol-Myers Squibb Company Melanokortin receptor modulátoraiként hasznos vegyületek és a vegyületeket tartalmazó gyógyszerkészítmények
US20050256130A1 (en) 2002-06-12 2005-11-17 Chemocentryx, Inc. Substituted piperazines
US7842693B2 (en) 2002-06-12 2010-11-30 Chemocentryx, Inc. Substituted piperazines
AU2003236500B9 (en) 2002-06-12 2009-07-02 Chemocentryx, Inc. 1-aryl-4-substituted piperazine derivatives for use as CCR1 antagonists for the treatment of inflammation and immune disorders
US7589199B2 (en) 2002-06-12 2009-09-15 Chemocentryx, Inc. Substituted piperazines
GB0315203D0 (en) 2003-06-28 2003-08-06 Celltech R&D Ltd Chemical compounds
WO2005035534A1 (fr) 2003-10-08 2005-04-21 Ono Pharmaceutical Co., Ltd. Composes a anneau bicyclique heterocyclique et a anneau tricyclique heterocyclique et medicaments les contenant
US20050124625A1 (en) 2003-10-21 2005-06-09 Salvati Mark E. Piperazine derivatives and their use as modulators of nuclear hormone receptor function
WO2005042516A2 (fr) 2003-10-22 2005-05-12 Neurocrine Biosciences, Inc. Ligands de recepteurs de la melanocortine, compositions et procedes associes
GB0325956D0 (en) 2003-11-06 2003-12-10 Addex Pharmaceuticals Sa Novel compounds
RU2006121990A (ru) 2003-11-21 2007-12-27 Эррэй Биофарма Инк. (Us) Ингибиторы протеинкиназ акт
US20060276465A1 (en) 2003-12-26 2006-12-07 Eisai R&D Management Co., Ltd. 1,2-di(cyclic) substituted benzene compounds
MY140489A (en) 2003-12-26 2009-12-31 Eisai R&D Man Co Ltd 1,2-di (cyclic) substituted benzene compounds
US7645755B2 (en) 2004-10-22 2010-01-12 Janssen Pharmaceutical N.V. Inhibitors of c-fms kinase
AU2005299837A1 (en) 2004-10-22 2006-05-04 Janssen Pharmaceutica, N.V. Inhibitors of c-fms kinase
CA2598489A1 (fr) 2005-02-16 2006-08-24 Schering Corporation Piperazine-piperidines a activite antagoniste cxcr3
CA2598418A1 (fr) 2005-02-16 2006-08-31 Schering Corporation Pyrazinyl-piperazine-piperidines substitutees heteroaryle a activite antagoniste cxcr3
EP1853583B1 (fr) 2005-02-16 2011-09-07 Schering Corporation Pyridyle a liaison amine et piperazine-piperidines substituees a activite agoniste cxcr3
EP1856097B1 (fr) 2005-02-16 2012-07-11 Schering Corporation Piperazine-piperidines pyridyl et phenyl substituees a activite antagoniste des cxcr3
CA2598456A1 (fr) 2005-02-16 2006-08-24 Schering Corporation Piperazines heterocycliques substituees a activite antagoniste cxcr3
EP1856098B1 (fr) 2005-02-16 2012-08-01 Schering Corporation Piperazine-piperidines pyrazinyl substituees a activite antagoniste des cxcr3
CN101146793A (zh) 2005-02-16 2008-03-19 先灵公司 具有cxcr3拮抗剂活性的新的杂环取代了的吡啶或苯基化合物
EA017278B9 (ru) 2005-06-22 2013-01-30 Кемосентрикс, Инк. Соединения азаиндазола и способы применения
US7777035B2 (en) 2005-06-22 2010-08-17 Chemocentryx, Inc. Azaindazole compounds and methods of use
US20080312215A1 (en) 2005-06-28 2008-12-18 Pharmacopeia Drug Discovery, Inc. Substituted [1,4]-diazepanes as CXCR3 antagonists and their use in the treatment of inflammatory disorders
US7754724B2 (en) 2005-06-30 2010-07-13 Dow Agrosciences Llc N-substituted piperazines
TW200738701A (en) 2005-07-26 2007-10-16 Du Pont Fungicidal carboxamides
US7781437B2 (en) 2005-10-11 2010-08-24 Schering Corporation Substituted heterocyclic compounds with CXCR3 antagonist activity
BRPI0617489A2 (pt) 2005-10-18 2011-07-26 Janssen Pharmaceutica Nv compostos, composiÇço e uso de ditos compostos para inibir a flt3 cinase
US20090143413A1 (en) 2005-11-29 2009-06-04 Adams Alan D Thiazole Derivatives as CXCR3 Receptor Modulators
US20070126158A1 (en) 2005-12-01 2007-06-07 3M Innovative Properties Company Method of cleaning polymeric mold
US20100286191A1 (en) 2005-12-12 2010-11-11 Samuel Rachel G 2-Arylthiazole Derivatives as CXCR3 Receptor Modulators
WO2007076318A2 (fr) 2005-12-21 2007-07-05 Smithkline Beecham Corporation Antagonistes de cxcr3 dérivés du camphre
WO2007100610A2 (fr) 2006-02-23 2007-09-07 Merck & Co., Inc. Derives de pyridine, de pyrimidine et de pyrazine en tant que modulateurs du recepteur cxcr3
AR059962A1 (es) 2006-03-21 2008-05-14 Schering Corp Compuestos de piridina sustituida con heterociclos con actividad antagonista de cxcr3
ES2389678T3 (es) 2006-04-20 2012-10-30 Janssen Pharmaceutica Nv Un inhibidor de la quinasa C-Kit para su uso en el tratamiento de tumores del estroma gastrointestinal o mastocitosis
US7807671B2 (en) 2006-04-25 2010-10-05 Bristol-Myers Squibb Company Diketo-piperazine and piperidine derivatives as antiviral agents
FR2903405B1 (fr) 2006-07-04 2011-09-09 Pasteur Institut Composes a effet potentialisateur de l'activite de l'ethionamide et leurs applications
CA2658417A1 (fr) 2006-07-14 2008-01-17 Schering Corporation Composes de piperazine substitues heterocycliques presentant une activite antagoniste de cxcr3
WO2008013622A2 (fr) 2006-07-27 2008-01-31 E. I. Du Pont De Nemours And Company Amides azocycliques fongicides
AR064609A1 (es) 2006-12-22 2009-04-15 Schering Corp Piperazinas sustituidas, composiciones farmaceuticas que las comprenden y su uso en el tratamiento de enfermedades mediadas por el receptor de quimiocinas cxcr3.
WO2008091594A2 (fr) 2007-01-24 2008-07-31 E. I. Du Pont De Nemours And Company Mélanges fongicides
JP5337711B2 (ja) 2007-01-25 2013-11-06 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー 殺菌性アミド
MX2010001400A (es) 2007-08-03 2010-04-22 Schering Corp Metodo para tratar enfermedades mediadas cxcr3 usando piperazinas heterociclicas sustituidas.
TWI428091B (zh) 2007-10-23 2014-03-01 Du Pont 殺真菌劑混合物
US20110124867A1 (en) 2007-12-18 2011-05-26 Schering Corporation Process and intermediates for the Synthesis of heterocyclic Substituted Piperazines with CXCR3 Antagonist Activity
EP2260032A2 (fr) 2008-01-25 2010-12-15 E. I. du Pont de Nemours and Company Composés hétérocycliques fongicides
MX2010007974A (es) 2008-01-25 2010-08-04 Du Pont Amidas fungicidas.
PE20091576A1 (es) 2008-02-19 2009-11-05 Sanofi Aventis DERIVADOS DE 3-(AMIDO O SULFAMIDO)-4-(4-AZINIL SUSTITUIDO)BENZAMIDA COMO INHIBIDORES DEL RECEPTOR DE QUIMIOQUINAS CxCR3
ES2392485T3 (es) 2008-04-30 2012-12-11 Bayer Cropscience Ag Ésteres y tioésteres de ácido tiazol-4-carboxílico como agentes fitoprotectores
WO2010037479A1 (fr) 2008-10-01 2010-04-08 Bayer Cropscience Ag Thiazoles substitués par un hétérocyclyle comme agent phytosanitaire
KR101052065B1 (ko) 2008-10-15 2011-07-27 한국과학기술연구원 칼슘이온 채널 조절제로서 유효한 피라졸릴메틸아민-피페라진 유도체와 이의 제조방법
US8618137B2 (en) 2008-12-02 2013-12-31 E I Du Pont De Nemours And Company Fungicidal heterocyclic compounds
EP2376487B1 (fr) 2008-12-11 2016-01-06 Bayer Intellectual Property GmbH Thiazoloximéther et thiazolhydrazone comme agent phytosanitaire
JP5807971B2 (ja) * 2009-04-27 2015-11-10 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｘｃｒ３受容体アンタゴニスト
US8362249B2 (en) 2009-04-27 2013-01-29 Boehringer Ingelheim International Gmbh CXCR3 receptor antagonists
EP2272846A1 (fr) 2009-06-23 2011-01-12 Bayer CropScience AG Dérivés de thiazolylpipéridine en tant que fongicide
BR112012002369A2 (pt) 2009-08-12 2019-09-24 Syngenta Participations Ag heterociclos microbicidas
UA107938C2 (en) 2009-08-12 2015-03-10 Syngenta Participations Ag Heterocycles with microbicidal properties
WO2011051243A1 (fr) 2009-10-29 2011-05-05 Bayer Cropscience Ag Combinaisons de composé actif
KR20120101019A (ko) 2009-10-30 2012-09-12 바이엘 크롭사이언스 아게 헤테로아릴피페리딘 및 -피페라진 유도체
PL2516426T3 (pl) 2009-12-21 2016-03-31 Bayer Cropscience Ag Bis(difluorometylo)pirazole jako fungicydy
WO2011084985A1 (fr) 2010-01-07 2011-07-14 Boehringer Ingelheim International Gmbh Antagonistes des récepteurs cxcr3
BR112012027762B1 (pt) 2010-04-28 2018-06-05 Bayer Intellectual Property Gmbh Derivados de cetoheteroarilpiperidina e - piperazina como fungicidas
US8815775B2 (en) 2010-05-18 2014-08-26 Bayer Cropscience Ag Bis(difluoromethyl)pyrazoles as fungicides
KR20130109975A (ko) 2010-05-20 2013-10-08 이 아이 듀폰 디 네모아 앤드 캄파니 살진균제 옥심 및 하이드라존
JP2013528169A (ja) 2010-05-27 2013-07-08 バイエル・クロップサイエンス・アーゲー 殺菌剤としてのピリジニルカルボン酸誘導体
US20120122928A1 (en) 2010-08-11 2012-05-17 Bayer Cropscience Ag Heteroarylpiperidine and -Piperazine Derivatives as Fungicides
US8759527B2 (en) 2010-08-25 2014-06-24 Bayer Cropscience Ag Heteroarylpiperidine and -piperazine derivatives as fungicides
CA2815716C (fr) 2010-10-27 2019-06-11 Bayer Intellectual Property Gmbh Heteroarylpiperidine et derives d'heteroarylpiperidine comme fongicide
CN103228645A (zh) 2010-11-25 2013-07-31 先正达参股股份有限公司 杀微生物杂环
CN103384470A (zh) 2010-12-17 2013-11-06 纳幕尔杜邦公司 杀真菌偶氮环酰胺
JP6326231B2 (ja) 2011-02-01 2018-05-16 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ 殺菌剤としてのヘテロアリールピペリジン誘導体及びヘテロアリールピペラジン誘導体
US20130317064A1 (en) 2011-02-10 2013-11-28 Syngenta Participations Ag Microbiocidal pyrazole derivatives
CN103402985A (zh) 2011-02-10 2013-11-20 先正达参股股份有限公司 杀微生物的吡唑衍生物
CN102827073A (zh) 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
US10004232B2 (en) 2011-09-15 2018-06-26 Bayer Intellectual Property Gmbh Piperidine pyrazoles as fungicides
CN103889982A (zh) 2011-10-18 2014-06-25 先正达参股股份有限公司 杀微生物的吡唑衍生物
WO2013056911A1 (fr) 2011-10-18 2013-04-25 Syngenta Participations Ag Dérivés de pyrazole microbiocides
US8642774B2 (en) 2011-12-08 2014-02-04 Boehringer Ingelheim International Gmbh Compounds
US8889677B2 (en) 2012-01-17 2014-11-18 Boehringer Ingellheim International GmbH Substituted triazoles useful as mGlu5 receptor modulators
ES2798289T3 (es) 2012-01-25 2020-12-10 Novartis Ag Compuestos heterocíclicos y métodos para su uso
CN104093715B (zh) * 2012-02-02 2017-04-26 埃科特莱茵药品有限公司 4‑(苯并咪唑‑2‑基)‑噻唑化合物及相关氮杂衍生物
WO2013127784A1 (fr) 2012-03-02 2013-09-06 Syngenta Participations Ag Dérivés de pyrazole microbicides
WO2013127808A1 (fr) 2012-03-02 2013-09-06 Syngenta Participations Ag Dérivés de pyrazole microbicides
ES2617863T3 (es) * 2012-06-04 2017-06-20 Actelion Pharmaceuticals Ltd. Derivados de bencimidazol-prolina
WO2014062938A1 (fr) 2012-10-19 2014-04-24 Bristol-Myers Squibb Company Modulateurs du récepteur gamma orphelin associé aux rétinoïdes (rory)
WO2014075874A1 (fr) 2012-11-13 2014-05-22 Syngenta Participations Ag Dérivés microbicides de pyrazole
WO2014075873A1 (fr) 2012-11-13 2014-05-22 Syngenta Participations Ag Dérivés microbicides de pyrazole
US9643957B2 (en) 2012-12-11 2017-05-09 Takeda Pharmaceutical Company Limited Heterocyclic compounds having cholesterol 24-hydroxylase activity
EP3013821B1 (fr) 2013-06-24 2018-03-14 Bayer CropScience Aktiengesellschaft Dérivés d'acide pipéridènecarboxylique en tant que fongicides
WO2015011099A1 (fr) * 2013-07-22 2015-01-29 Actelion Pharmaceuticals Ltd Dérivés de 1-(pipérazin-1-yl)-2-([1,2,4]triazol-1-yl)-éthanone
EP3035800B1 (fr) 2013-08-22 2019-10-09 Merck Sharp & Dohme Corp. Composés inhibant l'activité enzymatique de la kinase à répétitions riches en leucine
AR099789A1 (es) * 2014-03-24 2016-08-17 Actelion Pharmaceuticals Ltd Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina
AR102256A1 (es) * 2014-10-15 2017-02-15 Actelion Pharmaceuticals Ltd Derivados biaromáticos básicos antibacterianos con sustitución de aminoalcoxi
TR201900680T4 (tr) * 2015-01-15 2019-02-21 Idorsia Pharmaceuticals Ltd CXCR3 Reseptör modülatörleri olarak hidroksialkil- piperazin türevleri.
AR103399A1 (es) * 2015-01-15 2017-05-10 Actelion Pharmaceuticals Ltd Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3

Also Published As

Publication number Publication date
MX2017009288A (es) 2017-10-11
PT3245203T (pt) 2019-02-08
AR103414A1 (es) 2017-05-10
US20180009799A1 (en) 2018-01-11
TR201900680T4 (tr) 2019-02-21
UA119805C2 (uk) 2019-08-12
TWI693221B (zh) 2020-05-11
EP3245203A1 (fr) 2017-11-22
CA2972952A1 (fr) 2016-07-21
DK3245203T3 (en) 2019-02-18
AU2016207988B2 (en) 2019-08-15
HRP20190024T1 (hr) 2019-02-22
TW201632519A (zh) 2016-09-16
HK1246789B (zh) 2019-11-22
IL253411A0 (en) 2017-09-28
JP6337218B2 (ja) 2018-06-06
LT3245203T (lt) 2019-02-11
KR20170102010A (ko) 2017-09-06
PE20171100A1 (es) 2017-08-07
CO2017008156A2 (es) 2017-11-30
AU2016207988A1 (en) 2017-08-31
ES2709985T3 (es) 2019-04-22
US10053457B2 (en) 2018-08-21
HUE042559T2 (hu) 2019-07-29
ZA201705486B (en) 2019-06-26
SG11201705617XA (en) 2017-08-30
MY187614A (en) 2021-10-04
RS58349B1 (sr) 2019-03-29
NZ734542A (en) 2023-02-24
EP3245203B1 (fr) 2018-11-14
JP2018502161A (ja) 2018-01-25
SA517381905B1 (ar) 2021-04-01
EA201791600A1 (ru) 2018-03-30
IL253411B (en) 2020-08-31
CN107250133A (zh) 2017-10-13
BR112017015093A2 (pt) 2018-04-17
PL3245203T3 (pl) 2019-05-31
WO2016113344A1 (fr) 2016-07-21
CY1121361T1 (el) 2020-05-29
TN2017000278A1 (en) 2019-01-16
CL2017001831A1 (es) 2018-05-11
PH12017501280A1 (en) 2018-01-15
KR101967083B1 (ko) 2019-04-08
CN107250133B (zh) 2020-09-15
EA032927B1 (ru) 2019-08-30
CA2972952C (fr) 2021-01-05
PH12017501280B1 (en) 2018-01-15
SI3245203T1 (sl) 2019-03-29

Similar Documents

Publication Publication Date Title
MA41337A (fr) Dérivés de l&#39;hydroxyalkyl pipérazine utilisés comme modulateurs du récepteur cxcr3
MA42109A (fr) Amides hétérocycliques utilisés en tant qu&#39;inhibiteurs de kinase
CL2018000730A1 (es) Compuestos heterocíclicos y usos de los mismos
MA39995B1 (fr) Composés destinés à traiter l&#39;amyotrophie spinale
NZ730794A (en) Modulators of cystic fibrosis transmembrane conductance regulator
PH12016501440A1 (en) Novel heterocyclic compounds
PE20151781A1 (es) Piridonamidas como moduladores de canales de sodio
CL2018003504A1 (es) Derivados de carbonucleósidos sustituidos útiles como agentes antineoplasicos.
MA42230B1 (fr) Dérivés bicycliques, leur procédé de préparation, et compositions pharmaceutiques les contenant
MA42410A (fr) Oxystérols et leurs méthodes d&#39;utilisation
NI201400031A (es) Derivados de ( 4 - fenilimidazol - 2 - il ) etilamina útiles como moduladores de canal de sodio
MA39317A1 (fr) Dérivés de nucléosides à substitution 4&#39;-difluorométhyle utilisés en tant qu&#39;inhibiteurs de la réplication de l&#39;arn du virus de la grippe
UY31254A1 (es) Derivados sutituidos de n4-(5-metil-1h-pirazol-3-il)- 1,3,5-triazina-2,4-diamina, sus enantiómeros, sales farmacéuticamente aceptables de los mismos, composiciones, procesos de preparación y aplicaciones
UY32156A (es) Derivados sustituidos de la n2 - [1-(5 - fluoropirimidin -2-il) etil] - n4 - (1-metil - 1h-imidazol - 4 - il)) - pirimidina - 2,4 - diaminas y sus sales farmacéuticamente aceptables, proceso de preparación, composiciones conteniéndolos y aplicaciones.
UY31481A1 (es) Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones
MA46101B1 (fr) Modulateurs allostériques positifs du récepteur muscarinique m1
MA40225B1 (fr) Composés dihydroisoquinolinone substitués
MA40281B1 (fr) Composés de pyrazole et leur utilisation en tant qu&#39; agents de blocage des canaux calciques de type t
MA37142B1 (fr) Dérivés de dihydro-benzo-oxazine et de dihydro-pyrido-oxazine
UY31885A (es) Derivados de las 1, 3, 5-triazina-2, 4-diaminas-6-sustituidas-n-sustituidas y sales farmacéuticamente aceptables de los mismos, composiciones y aplicaciones.
EA201992679A1 (ru) N-замещенные индольные производные
ECSP17069696A (es) Compuestos novedosos
MA39152B1 (fr) Cyclopentanes substitués en 1,2 utilisés comme antagonistes du récepteur d&#39;orexine
CL2019001991A1 (es) Moduladores del receptor de estrógeno.
MX2017011978A (es) Analogos deuterados de etifoxina, sus derivados y usos de estos.